Owlstone Medical from Cambridge raises $35 million for its breathalyser-based diagnostics solution

Retrieved on: 2018-10-01 15:41:15

Tags for this article:

Biotechnology

Biomarkers

Click the tags to see associated articles and topics

Owlstone Medical from Cambridge raises $35 million for its breathalyser-based diagnostics solution. View article details on hiswai:

Excerpt

<div>The current funding deal was led by <b>Horizons Ventures</b>, joined by a group of strategic investors including Ventura Capital and Foxconn Technologies ...</div>

Article found on:

View Original Article